November 16, 2022

Asmadroid® dramatically boosted users’ asthma cognizance levels. In this digital age, future asthma self-management apps could be a valuable and engaging instructional platform for asthmatic patients, particularly the younger generations of any society. Asthma is a chronic medical disorder characterized by wheezing, intermittent shortness of breath, and chest tightness, often at night or early in...

Social support and depression of the caregiver influence medication adherence and asthma control in children. Healthcare practitioners are encouraged to consider the social position of children with asthma and provide the appropriate type of family assistance, such as diagnosing and monitoring caregivers for signs of depression, and linking them with mental health resources. Asthma is...

This 52-week phase 3 atopic dermatitis (AD) study indicates that upadacitinib with topical corticosteroids has the potential to be a successful and well-tolerated long-term treatment option for people with moderate-to-severe atopic dermatitis. Atopic dermatitis (AD) causes skin-related disability and burden over the long run. Over the course of 20 to 30 years, most AD patients...

In patients with moderate-to-severe atopic dermatitis (AD), dupilumab significantly reduces hospitalization rates and hospitalization length related to AD. Atopic dermatitis (AD), a chronic inflammatory skin disease, may necessitate inpatient hospitalization for refractory cases, severe flares (exacerbations), and infections. A U.S. study also found that 18.9% of hospitalized individuals with a primary diagnosis of AD or...

Long-term nemolizumab therapy in patients with AD and moderate-to-severe pruritus significantly improves pruritus, AD, and quality of life. Pruritus is a distinguishing symptom of atopic dermatitis (AD), an inflammatory skin disorder that affects up to 25 percent of children and 5 percent of adults globally. The exact cause of pruritus in AD is unknown, but...

ATTR-CM treatment is difficult, in most cases, but diflunisal is a promising treatment option for wild-type ATTR-CM. Treatment options for transthyretin amyloid cardiomyopathy (ATTR-CM) have historically been either risky or lacking in long-term efficacy. Treating ATTR-CM is, in most cases, significantly improved when it is discovered early, although this poses some unique challenges of its...

IL-6 levels have been found to correlate with other autoimmune conditions, and this study provides some evidence that it is also a biomarker of NMOSD disease activity. Currently, there are no widely accepted soluble markers for disease progression or activity of neuromyelitis optica spectrum disorder (NMOSD). This article, published in the Journal of Neuroimmunology, analyzed...